MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03584nam a22003257a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KENaKMTC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20251027110114.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
251027b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323554954 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0323554954 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
DLC |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM262.R67 2021 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Rosenthal Laura D. |
| Relator term |
Author |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Lehne's pharmacotherapeutics for advanced practice nurses and physician assistants/ |
| Statement of responsibility, etc |
by Laura D. Rosenthal and Jacqueline Rosenjack Burchum |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd.edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
St. Louis, Missouri: |
| Name of publisher, distributor, etc |
Elsevier, |
| Date of publication, distribution, etc |
c2021 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxix, 913 pages : |
| Other physical details |
illustrations, portraits ; |
| Dimensions |
28 cm |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Preceded by: Lehne's pharmacotherapeutics for advanced practice providers / Laura D. Rosenthal, Jacqueline Rosen jack Burchum. [2018] |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes Bibliographical references and Index |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
CONTENTS<br/>Unit I. Introduction--<br/>Unit II. Basic principles of pharmacology--<br/>Unit III. Drug therapy across the life span--<br/>Unit IV. Peripheral nervous system drugs--<br/>Unit V. Central nervous system drugs--<br/>Unit VI. Drugs for pain--<br/>Unit VII. Psychotherapeutic drugs--<br/>Unit VIII. Substance use disorders--<br/>Unit IX. Drugs that affect the heart, blood vessels, blood, and blood volume--<br/>Unit X. Drugs for endocrine disorders--<br/>Unit XI. Women's health--<br/>Unit XII. Men's health--<br/>Unit XIII. Anti-inflammatory, antiallergic, and immunologic drugs--<br/>Unit XIV. Drugs for bone and joint disorders--<br/>Unit XV. Respiratory tract drugs--<br/>Unit XVI. Gastrointestinal drugs--<br/>Unit XVII. Nutrition and complementary therapies--<br/>Unit XVIII. Therapy of infectious and parasitic diseases--<br/>Unit XIX. Cancer therapy--<br/>Unit XX. Drugs for eyes, ears, and skin--<br/>Unit XXI. Drug therapy for acute care.<br/><br/> |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
"Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 2nd Edition, builds on the same foundation of clearly explained, up-to-date, and clinically current content as the trusted Lehne undergraduate text, while focusing on the information that advanced practice nurses and Physician Assistants specifically need for safe and effective prescribing. Three introductory chapters provide foundational content for new prescribers in the areas of prescriptive authority, rational drug selection, prescription writing, and promoting positive outcomes of drug therapy. Core drug chapters are focused on the drugs that prescribers will most commonly see in clinical practice. A sharp focus is also placed on pharmacotherapeutic decision-making, with Black Box Warnings and new bulleted Key Prescribing Considerations features. Carefully focused pharmacotherapeutic content reflects the drugs most commonly seen and used by prescribers, with emphasis not on the first drug discovered or developed in each class but on the agents most often used today. Primary care drugs are addressed first in each chapter as appropriate, followed by acute care drugs. The second edition features completely new chapters on Genetic and Genomic Considerations, Muscarinic Antagonists and Immunomodulators, and updated content throughout. It's everything advanced practice nursing and Physician Assistant students need to be safe and effective prescribers!"--taken from publisher description<br/> |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacokinetics |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacological Phenomena |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical Preparations administration & dosage |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Therapy methods |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs Dosage |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Burchum Jacqueline Rosenjack |
| Relator term |
Author |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books |
| Intials |
SO |
